The Next Generation Biotech Media
On August 4th, nearly two months since the inception of vaccine testing, Novavax announced preliminary data from its Phase 1 trial. The vaccine produced a promising immune response in the …
Read More
By Judy Ya-Hsuan Lin The clinical-stage biotech which hasn’t launched any product in the market previously is gearing towards an ambitious deadline to counter the COVID-19 pandemic. Maryland-based Novavax is …
Read More
By Sahana Shankar, Ph.D. Candidate As opposed to antibodies that bind to the receptor-binding domain, scientists discover a new antibody that binds to the N-Terminal Domain of the SARS-CoV-2’s spike …
Read More
By Ruchi Jhonsa, Ph.D. The BIO Digital Conference held between June 8-12, saw over 7000 participants from 64 countries come together for a two-day virtual meeting to discuss the progress …
Read More
By Sahana Shankar, Ph.D. Candidate European researchers report that SARS-CoV-2’s entry into the host cells is facilitated by Neuropilin-1 (NRP1), a cell receptor that, when inhibited with a monoclonal antibody, …
Read More
By Ruchi Jhonsa, Ph.D. While the vaccine’s effectiveness in humans is still in question, Novavax is already flooded with cash flow from various sources for the testing and development of …
Read More
In light of the prolonged global transmission of the SARS-CoV-2 virus and a probable long-term battle against the COVID-19 pandemic, a symposium on the topic “TAIWAN is Helping: AI x …
Read More
By Sahana Shankar, Ph.D. Candidate Scientists from Humabs Biomed and the University of Washington, Seattle, demonstrate that monoclonal antibody from a SARS survivor can effectively neutralize the SARS-CoV-2 virus. The …
Read More
By Vidya Kunnathully, Ph.D. While lockdowns start to ease in some parts of the world, others continue to extend it, fearing a fresh wave of infections. Nevertheless, the one question …
Read More
By Ishani Dasgupta, Ph.D. The COVID-19 pandemic has brought about an unprecedented impact on global health and safety, with several countries reporting a steady increase in new cases. This further …
Read More